We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$451M
AUM Growth
+$3.17M
Cap. Flow
-$31.2M
Cap. Flow %
-6.92%
Top 10 Hldgs %
34.82%
Holding
113
New
12
Increased
22
Reduced
44
Closed
8

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$11.3M
2
ULTA icon
Ulta Beauty
ULTA
+$8.65M
3
DGX icon
Quest Diagnostics
DGX
+$8.65M
4
META icon
Meta Platforms (Facebook)
META
+$8.06M
5
AMZN icon
Amazon
AMZN
+$7.28M

Sector Composition

Rank Sector Weight
1 Technology 36.56%
2 Healthcare 24.42%
3 Communication Services 8.23%
4 Financials 8.22%
5 Industrials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
51
Gilead Sciences
GILD
$166B
$2.55M 0.57%
31,475
-200
-0.6% -$15.3K
BRK.B icon
52
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.53M 0.56%
13,800
-100
-0.7% -$17.7K
TCMD icon
53
Tactile Systems Technology
TCMD
$633M
$2.15M 0.48%
+69,500
New +$2.2M
ATO icon
54
Atmos Energy
ATO
$30.3B
$2.13M 0.47%
25,400
ZION icon
55
Zions Bancorporation
ZION
$10.2B
$2.08M 0.46%
44,000
+8,500
+24% +$378K
EW icon
56
Edwards Lifesciences
EW
$48.4B
$2.06M 0.46%
56,700
-300
-0.5% -$11.4K
MASI
57
DELISTED
Masimo
MASI
$2M 0.44%
23,100
-2,150
-9% -$190K
INGN icon
58
Inogen
INGN
$174M
$1.82M 0.4%
+19,200
New +$1.85M
CCI icon
59
Crown Castle
CCI
$34B
$1.81M 0.4%
18,150
+2,050
+13% +$210K
VZ icon
60
Verizon
VZ
$203B
$1.67M 0.37%
33,718
-600
-2% -$28.2K
SIVB
61
DELISTED
SVB Financial Group
SIVB
$1.67M 0.37%
+8,900
New +$1.57M
ULTA icon
62
Ulta Beauty
ULTA
$21.6B
$1.65M 0.37%
7,300
-35,940
-83% -$8.65M
T icon
63
AT&T
T
$170B
$1.45M 0.32%
49,116
ESRX
64
DELISTED
Express Scripts Holding Company
ESRX
$1.32M 0.29%
20,900
-12,032
-37% -$748K
C icon
65
Citigroup
C
$222B
$1.28M 0.28%
17,582
-200
-1% -$13.7K
GIS icon
66
General Mills
GIS
$20.4B
$1.27M 0.28%
24,600
MMM icon
67
3M
MMM
$95.1B
$1.15M 0.26%
6,578
+120
+2% +$20.8K
NBIX icon
68
Neurocrine Biosciences
NBIX
$18.2B
$1.08M 0.24%
17,700
-4,650
-21% -$245K
BCE icon
69
BCE
BCE
$20.3B
$1.03M 0.23%
22,111
DOC icon
70
Healthpeak Properties
DOC
$15.6B
$1.01M 0.22%
36,250
-300
-0.8% -$9.02K
PG icon
71
Procter & Gamble
PG
$353B
$1M 0.22%
11,002
ADI icon
72
Analog Devices
ADI
$181B
$999K 0.22%
11,600
-8,000
-41% -$645K
CMD
73
DELISTED
Cantel Medical Corporation
CMD
$998K 0.22%
10,600
-200
-2% -$15.8K
RGA icon
74
Reinsurance Group of America
RGA
$15.9B
$990K 0.22%
7,100
-3,600
-34% -$487K
XL
75
DELISTED
XL Group Ltd.
XL
$978K 0.22%
24,800
-93,600
-79% -$4M

Similar funds

De Burlo Group's Q3 2017 Portfolio in Review

As of Q3 2017, De Burlo Group held 113 positions worth $451M, up 0.71% from $448M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

De Burlo Group withdrew a net $31.2M in Q3 2017, closing 8 positions and reducing 44 holdings. Its most notable exit was Quest Diagnostics, an estimated $8.65M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 30% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, De Burlo Group opened a new position in Netflix worth $6.84M.

  • De Burlo Group's largest Q3 2017 buy was Netflix: 377,000 shares worth $6.84M.
  • De Burlo Group added most to American Tower in Q3 2017, an estimated $7.16M increase.
  • De Burlo Group's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $11.3M.
  • De Burlo Group fully exited Quest Diagnostics in Q3 2017, selling an estimated $8.65M.
  • De Burlo Group's ten largest holdings make up 35% of its $451M portfolio in Q3 2017.
  • De Burlo Group opened 12 new positions and closed 8 in Q3 2017.
  • De Burlo Group's portfolio value rose 0.71% quarter-over-quarter to $451M.

Based on De Burlo Group's 13F filing for Q3 2017, filed 2 Nov 2017.